Summary.-The amount of embryonic antigens (EA) was estimated in 13 BALB/c fibrosarcomata by in vitro cell mediated cytotoxicity of anti-embryo spleen cells and by quantitative absorption of an anti-embryo antiserum. A direct relationship between amount of EA and tumour growing capacity was found. EA were detected also on fast dividing testicular cells. It is suggested that EA expression on tumour cells is related to a cell membrane function controlling mitosis rather than to a function specifically related to the neoplastic status. Tumour take of low doses of 2 EA-bearing sarcomata was found to be enhanced in anti-embryo immune BALB/c mice in comparison with that in normal and anti-fibroblast immune mice.
THE PRESENCE of embryonic antigens (EA) on tumours induced by different agents has been demonstrated in various animal species and it has been ascertained that such antigens differ both from the individual ones which characterize chemically induced ttumours (Baldwin, Glaves and Vose 1972;  Menard, Colnaghi and Della Porta, 1973; Thomson and Alexander, 1973 ) and from the cross-reacting antigens carried by viral tumours (Ting et al., 1972; Kurth and Bauer, 1973) .
The function of EA on tumour cells is not clear: it is not yet known whether they are related specifically to neoplastic transformation, and conflicting results on their behaviour as transplantation antigens have been reported. In anti-embryo immune animals, both with virus and with chemically induced tumours, either no effect (Ting, Rodrigues and Herberman, 1973; Baldwin, Glaves and Vose, 1974) , or protection (Coggin et al., 1971; Le Mevel and Wells, 1973) , or even enhancement (Castro et al., 1973) have been reported.
In a previous experiment (Menard et al., 1973) we demonstrated that expression of EA on DMBA induced murine fibrosarcomata increased during serial transplant in syngeneic host. In the present study, we investigated (1) the correlation between the amount of EA and the growth rate of sarcomata induced by different agents, (2) the specificity of EA ascertaining whether they can be demonstrated on cells other than tumoral or embryonic ones and (3) the influence of anti-embryo immunity on tuimour growth.
MATERIALS AND METHODS
Mice. BALB/c, C3Hf and C57BL mice of both sexes, maintained in this laboratory by brother x sister mating, were used.
Where immunodepressed animals w%ere needed, adult BALB/c mice w-ere thymectomized and total body irradiated 24 h later (450 rad).
Tuanours. Fibrosarcomata were induced in BALB/c mice by subcutaneous implantation of a teflon disc 15 mm in diameter, by a single subcutaneous injection of 50 ,ug of 7 ,12-dimethylbenz(a)anthracene (DMBA) in oil suspension, by exposing to 3-methylcholanthrene (MCA) BALB/c normal fibroblasts in diffusion chambers inserted in the abdominal cavity of BALB/c mice (Parmiani, Carbone and Lembo, 1973) , and by spontaneous transformation of BALB/c normal fibroblasts in in vitro long-term culture (Carbone, Piazza and Parmiani, 1974 In vivo challenge.-The growth of 2 DMBA-induced fibrosarcomata (No. 1 and 2), at the 15th and the 10th transplant generation respectively, was tested in BALB/c mice, untreated or immunized as above described, against embryo or fibroblastic cells. Animals were challenged on the opposite flank to that of immunization, 7 days after the last immunizing inoculum. All mice were examined 3 times weekly and 2 tumour diameters were measured. Tumour volume was calculated by the formula: A x B2 x 04, A being the larger and B the smaller diameter.
RESULTS

Amount of EA
The amount of EA in different fibrosarcomata was estimated by measuring the cytotoxic activity of anti-embryo spleen cells on the fibrosarcoma cells, and the absorbing capacity of fibrosarcoma cells for an anti-embryo serum. The results are reported in the Table. Ten of the 15 cytotoxic tests on 13 fibrosarcomata were positive, the immune lymphocytes giving a specific 51Cr release of over 20%. The 3 spontaneous tumours tested and 2 out of 5 teflon induced tumours were positive even at the early transplant generation, when the 2 tumours induced by chemical carcinogens were negative. Two of the 5 negative tumours were tested again at later transplants and found positive, as were 3 additional chemically induced tumours tested after more than 10 passages. Control lymphocytes sensitized against adult fibroblasts were tested on the same fibrosarcoma target cells and never found to be cytotoxic. Pertinent data are therefore not reported in the Table. Nine of the 13 fibrosarcomata were studied for their capacity to absorb the activity of the C57BL anti-embryo antiserum. The 3 fibrosarcomata which had a 43-57% specific 51Cr release when challenged with anti-embryo lymphocytes, absorbed more than 80% of the cytotoxic activity of the anti-embryo serum even at 5 x 106 cells, whereas the 2 fibrosarcomata with a 32-39% release caused 50% absorption at the same dose of absorbing cells. Three fibrosarcomata which were negative in the cell mediated test absorbed little of the activity of the anti-embryo 
Tumour growth in immunodepressed mice
As reported in the Table, there was a direct relationship between the 2 parameters selected to define the growing capacity of the 13 fibrosarcomata, since the fewer the cells needed to reach 50% tumour take, the faster was tumour growth. Two fibrosarcomata, as in the cytotoxic study, were tested both at early and late transplant generations and were found to increase their growing capacity after serial transplantation.
Correlation between tumour take and antiembryo cytotoxicity and nature of EA A comparative analysis of the data reported in the Table reveals that the tumours with a higher expression of EA had also a higher growing capacity. In particular, as depicted in Fig. 1 the prepubescent testicles only the fast dividing spermatogonia were observed whereas in that of adult testicles spermatozoa were also present. As shown in Fig. 2 , both types of cell suspension completely absorbed the serum activity while the control thymus cells were ineffective.
Tumour growth in immaune mice
The 2 DMBA induced fibrosarcomata tused in the challenge experiment were chosen from those shown to bear EA and not to grow in normal untreated mice at low doses of tumour cells, allowing detection of an enhancement phenomenon.
As shown in Fig. 3 , when anti-embryo immune mice were injected with low doses of tumour cells obtained from either of the 2 fibrosarcomata, the tumour take was higher than in normal or anti-fibroblast immune mice. However, when for one of the tumours a higher dose of cells was used for challenge, the tumour took similarly in all 3 groups but the growth rate was slower in mice immune to embryo cells than in those immune to fibroblastic cells or in untreated mice (Fig. 4) .
DISCUSSION
Our present results show that the expression of EA on tumour cells can vary widely and confirm our previous data (Menard et al., 1973) rapidly dividing testicular cells either of prepubescent or of adult mice. It should be noted that in the former case no mature spermatozoa known to bear EA (Artzt et al., 1973) were present. Other EA found in human and animal systems also correlate to mitotic activity: x-foetoprotein and CEA have been dernonstrated not only in embryos or tumours but also in regenerating lesions of the liver and of the digestive tract (Abelev, 1971; Laurence and Munro Neville, 1972) ; a common factor has been observed in the serum of pregnant or tumour bearing or scalped rats (Tyndall et al., 1972) ; a common antigen has been recently found in murine mammary carcinoma and in pregnant and lactating mammary glands but not in normal ones (Bertini, Forni and Comoglio, 1974 (Cikes and Friberg, 1971;  Lerner, Oldstone and Cooper, 1971; Pellegrino et al., 1972; Killander, Klein and Levin, 1974 mice immutnized against normal fibroblasts. At a higher cell dose the tumour incidence was the same in the 3 groups, although a decrease of tumour growth rate was observed in anti-embryo immune mice. This seems to indicate that enhancement and resistance depend on the ratio between the level of immunity and the amount of antigen. It has been shown that a mild degree of immunity may enhance tumour growth (Prehn and Lappe, 1971) . In our experiment a high antibody-antigen ratio seems to stimulate tumour growth whereas an increased amount of antigen failed to enhance or even afford detectable protection. It is noteworthy that enhancement of MCA induced tumours by an anti-allogeneic embryo presensitization has already been reported in BALB/c mice (Castro et al., 1973) and that attempts to obtain an active anti-embryo antiserum in the same strain of mice were unsuccessful (Ting, Ortaldo and Herberman, 1973) . Conversely, in C57BL mice the anti-embryo immunity resulted in protection against a MCA induced tumour bearing a strong tumour transplantation antigen (Le Mevel and WVells, 1973) . The conflicting results obtained with BALB/c or C57BL mice may be due to genetically determined balance between antibody and antigen or to the fact that the response to strong individual antigens may hamper the expression of the enhancing phenomenon.
